×
模态框(Modal)标题
在这里添加一些文本
Close
Close
Submit
Cancel
Confirm
×
模态框(Modal)标题
在这里添加一些文本
Close
×
主办:
上海医药工业研究院
中国药学会
ISSN 1672-9188 CN 31-1939/R SLYHAA
导航切换
World Clinical Drug
Home
About Journal
Editorial Board
Guide to Authors
Browse
Just Accepted
Current Issue
Archive
Featured Articles
Topic
Most Accessed
Most Download
Most Cited
E-mail alert
RSS
News
Policies and Ethics
Subscribe
Advertisement
Contacts Us
中文
The effect of rituximab adjuvant GDP regimen on non-Hodgkin lymphoma and its influence on TK-1, FASL and PDGF-BB
JI Junqin, GUO Zhiqiang, XU Ning, ZHAO Yijing, YIN Liling, LIU Jinling
World Clinical Drug . 2025, (
12
): 1263 . DOI: 10.13683/j.wph.2025.12.010